AKTS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Aktis Oncology Inc (AKTS) Moving Averages Convergence Divergence (MACD) indicator is -0.67, suggesting AKTS is Sell.

Aktis Oncology Inc (AKTS) 20-Day simple moving average is 18.538, while Aktis Oncology Inc (AKTS) share price is $17.98, making it Sell.

Aktis Oncology Inc (AKTS) 60-Day simple moving average is 19.42, while Aktis Oncology Inc (AKTS) share price is $17.98, making it Sell.

Technical Analysis for AKTS

Technical Sentiment Analysis for Aktis Oncology Inc (AKTS) As of 2026-03-31, Aktis Oncology Inc (AKTS) is exhibiting a Sell technical sentiment. Our proprietary analysis, which aggregates 11 technical signals, shows that 4 indicators are flashing buy, while 7 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for AKTS stands at 47.672, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.67, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 30.591 and the Commodity Channel Index (CCI) at -40.512 further confirm a -1.16 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, AKTS is trading below its 60-day moving average of $19.42 and below its 200-day long-term moving average of $19.42. Key price levels to watch include the immediate resistance at $20.015 and strong support at $15.035. A break above $20.015 could signal a bull continuation, while falling below $15.035 may test the next Fibonacci floor at $12.388.

Aktis Oncology Inc (AKTS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	10.055	12.388	15.035	17.368	20.015	22.348	24.995
Fibonacci	12.388	14.29	15.465	17.368	19.27	20.445	22.348

Aktis Oncology Inc (AKTS) Technical Indicators

2026-03-31

Name	Value
RSI_14	47.672
STOCHk_14_3_3	30.591
STOCHd_14_3_3	24.188
CCI_20	-40.512
AO_5_34	-1.39
MOM_10	-1.16
MACD_12_26_9	-0.67

Aktis Oncology Inc (AKTS) Relative Strength Index (RSI) is 47.672, creating a Neutral signal.

Aktis Oncology Inc (AKTS) Stochastic Oscillator is 30.591, creating a Neutral signal.

Aktis Oncology Inc (AKTS) Stochastic RSI is 24.188, creating a Neutral signal.

Aktis Oncology Inc (AKTS) Commodity Channel Index (CCI) is -40.512, creating a Neutral signal.

Aktis Oncology Inc (AKTS) Awesome Oscillator is -1.39, creating a Sell signal.

Aktis Oncology Inc (AKTS) Momentum is -1.16, creating a Sell signal.

Aktis Oncology Inc (AKTS) MACD is -0.67, creating a Sell signal.

Aktis Oncology Inc (AKTS) Moving Average

2026-03-31

Period	Simple	Signal
MA_5	17.212	Buy
MA_10	17.683	Buy
MA_20	18.538	Sell
MA_60	19.42	Sell
MA_200	19.42	Sell
MA_250	19.42	Sell

Aktis Oncology Inc (AKTS) 5-Day simple moving average is 17.212, while Aktis Oncology Inc (AKTS) share price is $17.98, making it a Buy.

Aktis Oncology Inc (AKTS) 10-Day simple moving average is 17.683, while Aktis Oncology Inc (AKTS) share price is $17.98, making it a Buy.

Aktis Oncology Inc (AKTS) 20-Day simple moving average is 18.538, while Aktis Oncology Inc (AKTS) share price is $17.98, making it a Sell.

Aktis Oncology Inc (AKTS) 60-Day simple moving average is 19.42, while Aktis Oncology Inc (AKTS) share price is $17.98, making it a Sell.

Aktis Oncology Inc (AKTS) 200-Day simple moving average is 19.42, while Aktis Oncology Inc (AKTS) share price is $17.98, making it a Sell.

Aktis Oncology Inc (AKTS) 250-Day simple moving average is 19.42, while Aktis Oncology Inc (AKTS) share price is $17.98, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for AKTS?

The overall technical consensus for Aktis Oncology Inc (AKTS) is currently Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 2 buy signals and 3 sell signals.

What are the key support and resistance levels for Aktis Oncology Inc (AKTS) today?

Based on pivot point calculations, Aktis Oncology Inc (AKTS) has an immediate support level at 15.035 and a major resistance level at 20.015. Traders also monitor the pivot point at 17.368 to determine the intraday trend direction.

Is Aktis Oncology Inc (AKTS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Aktis Oncology Inc (AKTS) is currently 47.672. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Aktis Oncology Inc (AKTS)?

Aktis Oncology Inc (AKTS) Moving Averages Convergence Divergence (MACD) indicator is -0.67, suggesting AKTS is Sell. This indicator helps identify potential trend reversals or momentum shifts for Aktis Oncology Inc.

How is Aktis Oncology Inc (AKTS) performing relative to its 200-day moving average?

Aktis Oncology Inc (AKTS) is currently trading at $17.98, which is below its 200-day simple moving average of 19.42. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.